Abstract | CONCLUSION: OBJECTIVES: This therapy was intended to control primary tumor without resection for better quality of life (QOL). METHODS: RESULTS: In terms of the primary response of primary tumor, 43 patients achieved a clinical complete response (CR). Moreover, in these patients no cancer cells were histopathologically found by biopsy, resulting in a response rate of 100% and a CR rate of 95.6%. During the median follow-up period of 1779 days (59 months) (range 110-3752 days), the 5-year survival rate and organ preservation rate were 89.8% and 80.7%, respectively.
|
Authors | Tohru Furusaka, Takeshi Asakawa, Akane Tanaka, Hiroshi Matsuda, Minoru Ikeda |
Journal | Acta oto-laryngologica
(Acta Otolaryngol)
Vol. 132
Issue 10
Pg. 1108-14
(Oct 2012)
ISSN: 1651-2251 [Electronic] England |
PMID | 22998559
(Publication Type: Journal Article)
|
Chemical References |
- Taxoids
- Docetaxel
- Cisplatin
- Fluorouracil
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
(administration & dosage, adverse effects)
- Carcinoma, Squamous Cell
(drug therapy, mortality, pathology, radiotherapy)
- Cisplatin
(administration & dosage, adverse effects)
- Cohort Studies
- Disease-Free Survival
- Docetaxel
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Female
- Fluorouracil
(administration & dosage, adverse effects)
- Follow-Up Studies
- Head and Neck Neoplasms
(drug therapy, pathology, radiotherapy)
- Humans
- Infusions, Intra-Arterial
(methods)
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Invasiveness
(pathology)
- Neoplasm Staging
- Prospective Studies
- Radiotherapy, Adjuvant
- Risk Assessment
- Salvage Therapy
(methods)
- Survival Analysis
- Taxoids
(adverse effects, therapeutic use)
- Tongue
(drug effects, radiation effects)
- Tongue Neoplasms
(drug therapy, mortality, pathology, radiotherapy)
- Treatment Outcome
|